KeyBank National Association’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,250
| Closed | -$1.55M | – | 1081 |
|
|
2023
Q2 | $1.55M | Hold |
15,250
| – | – | 0.01% | 409 |
|
|
2023
Q1 | $1.39M | Hold |
15,250
| – | – | 0.01% | 420 |
|
|
2022
Q4 | $579K | Hold |
15,250
| – | – | ﹤0.01% | 639 |
|
|
2022
Q3 | $383K | Hold |
15,250
| – | – | ﹤0.01% | 750 |
|
|
2022
Q2 | $463K | Hold |
15,250
| – | – | ﹤0.01% | 698 |
|
|
2022
Q1 | $500K | Buy |
+15,250
| New | +$500K | ﹤0.01% | 730 |
|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$1.01M | – | 1109 |
|
|
2021
Q3 | $1.01M | Hold |
10,000
| – | – | ﹤0.01% | 556 |
|
|
2021
Q2 | $1.42M | Buy |
10,000
+2,000
| +25% | +$283K | 0.01% | 453 |
|
|
2021
Q1 | $798K | Buy |
8,000
+2,000
| +33% | +$200K | ﹤0.01% | 657 |
|
|
2020
Q4 | $742K | Buy |
+6,000
| New | +$742K | ﹤0.01% | 634 |
|